Glucose levels, now on a smartphone. Sends auto text alerts.
Hands-off, no more plugging in and waiting.
Helps you act & stay ahead of your diabetes.
Insights to help you make better lifestyle decisions. Share with care partner.
The Medtronic Pharmacy Offer is here to help customers pay for their out-of-pocket prescription costs, including deductible, co-insurance, and co-payment. Check your eligibility by filling out your information below.
1 – Guardian™ Connect CGM Starter Kit
1 – Box of Guardian™ Sensor 3 (5-pack)
See above for terms and conditions. Certain restrictions apply.
A member of our team will reach out to you about your eligibility. If you have questions please contact us at 888-882-8602.
* ELIGIBILITY REQUIREMENTS FOR THE GUARDIAN™ CONNECT SYSTEM COPAY CARD:
Open to customers with commercial prescription insurance and who are not enrolled in any government-funded program that pays for prescription devices or treatments. This program is not open to uninsured customers or customers enrolled in any federal, state, or government-funded healthcare program such as Medicare, Medicare Advantage, Medicare Part D, Medicaid, Medigap, Veterans Affairs (VA), the Department of Defense (DoD) or TRICARE®, or where prohibited by law. Cash Discount Cards and other non-insurance plans are not valid as primary under this offer. If at any time a customer becomes enrolled under any such federal, state, or government-funded healthcare program, he/she will no longer be able to use this card and must call 888-882-8602 to stop participation. Restrictions may apply. Offer subject to change or discontinuation without notice. This is not health insurance. This offer is not valid at retail pharmacies.
∆ Smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance and provides access to Sugar.IQ™ insights that can inform users of clinically relevant glucose patterns.
GUARDIAN™ CONNECT IMPORTANT SAFETY INFORMATION:
The Guardian™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide.
SUGAR.IQ™ APP IMPORTANT SAFETY INFORMATION:
The Sugar.IQ™ app (MMT-8100) helps manage diabetes by facilitating the logging and display of meal entries and sensor glucose (SG) data, tracking meal log entries, reporting insights of how meals affect glucose levels, and supporting good choices and trends with motivational messages. The app serves as an additional display for real-time CGM data from the Guardian™ Connect system through the CareLink™ Personal software. It is not intended to provide medical advice and should not be relied upon for such purpose. The app is not intended to replace the real-time display of the CGM data on the Guardian™ Connect app, control any functions of the connecting device, calculate insulin or other drug doses, or modify date or control functions of the Guardian™ Connect system. All therapy decisions should be made by the app user based on blood glucose (BG) measurements obtained from a BG meter. Changes to treatment should only be made in consultation with a healthcare professional (HCP). For complete details, consult the user guide.
The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices and not on values provided by the system.
CARELINK™ SOFTWARE IMPORTANT SAFETY INFORMATION:
The CareLink™ software is intended for use as a tool to help manage diabetes. The purpose of the software is to take information transmitted from insulin pumps, glucose meters and continuous glucose monitoring systems, and turn it into CareLink™ reports. The reports provide information that can be used to identify trends and track daily activities—such as carbohydrates consumed, meal times, insulin delivery, and glucose readings. NOTE: CareLink™ report data is intended for use as an adjunct in the management of diabetes only and NOT intended to be relied upon by itself. Patients should consult their healthcare providers familiar with the management of diabetes prior to making changes in treatment. For more details, please consult important safety information and the appropriate CareLink™ user guide.
© Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.